language_icon
EN
HI

Sun Pharma Advanced Research Company Share price

SPARC

124.06

3.72 (3.09%)
NSE
BSE
Last updated on 2 Apr, 2026 | 15:54 IST
Today's High

124.75

Today's Low

116.12

52 Week Low

108.00

52 Week High

204.40

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Sun Pharma Advanced Research Company Chart

Sun Pharma Advanced Research Company Share Key Metrics

Volume
9.40 L
Market Cap
4025.74 CR
LTQ@LTP
100@124.06
ATP
121.57
Var Margin
24.39 %
Circuit Range
96.28-144.4
Delivery %
24.23 %
Value
11.42 CR
ASM/GSM
No
Market Lot
1

Summary

At 2 Apr, 2026 | 15:54, Sun Pharma Advanced Research Company share price stands at ₹124.06, showing a 3.72% 3.09 for the day. The stock’s intraday movement has stayed between ₹116.12 and ₹124.75, while on a 52-week basis it has fluctuated from ₹108.00 to ₹204.40.
In terms of trading activity, Sun Pharma Advanced Research Company has recorded a volume of 939621 shares, with a market capitalisation of ₹324499558. The stock’s Average Traded Price (ATP) stands at ₹12157, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 100,12406. The stock operates within a circuit range of ₹96.28-144.4, with a Value of ₹11.42 CR. The Delivery Percentage for the day is 24.23%. Additionally, Sun Pharma Advanced Research Company currently falls under the No framework, and trades with a market lot size of 1.

Sun Pharma Advanced Research Company Fundamentals

View More
P/E Ratio

0

P/B Ratio

-9.19

Div. Yield

0

Sector P/E

21.12

Sector P/B

2.65

Sec. Div. Yield

1.22

Sun Pharma Advanced Research Company Resistance and Support

Pivot 120.29

Resistance

First Resistance

122.35

Second Resistance

124.36

Third Resistance

126.42

Support

First Support

118.28

Second Support

116.22

Third Support

114.21

Sun Pharma Advanced Research Company Futures & Options

Data Not Found

Sun Pharma Advanced Research Company Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

65.67%

Mutual Fund

0.76%

Insurance

0%

Foreign Institutional Investors

2.04%

Domestic Institutional Investors

0.01%

Retail

31.52%

Others

0%

Total Promoters
MAR '25
65.67%
JUN '25
65.67%
SEP '25
65.67%
DEC '25
65.67%

Sun Pharma Advanced Research Company Corporate Actions

DateAgenda
2026-02-09Quarterly Results
2026-01-14To consider issue of Warrants & ESOP
2025-11-10Quarterly Results
2025-08-04Quarterly Results
2025-05-19Audited Results
2025-02-10Quarterly Results

Sun Pharma Advanced Research Company News

Sun Pharma Advanced Research Company Ltd - 532872 - Announcement under Regulation 30 (LODR)-Change in Management

SPARC announced Dr. Shravanti Bhowmik's resignation as VP, Operations Management, effective March 31, 2026. Simultaneously, Narendra Lakkad has been appointed as Head - Corporate Development and Operations Management, effective April 01, 2026, bringing prior experience from Sun Pharma group and Shantilal Shanghvi Foundation.
Mar 27 2026 18:03:00

Sun Pharma Advanced Research Company Limited

Sun Pharma Advanced Research accepted the resignation of Dr. Shravanti Bhowmik, VP, Operations Management, effective March 31, 2026. Concurrently, Mr. Narendra Lakkad was appointed as Head - Corporate Development and Operations Management, effective April 01, 2026, bringing his extensive experience within the Sun Pharma group to this role.
Mar 27 2026 18:03:00
Read More

About Sun Pharma Advanced Research Company

NSE : 14788  
BSE : 532872  
ISIN : INE232I01014  

Sun Pharma Advanced Research Company Management

NamePosition
Mr. Dilip S Shanghvi Chairman & Non-Exe.Director
Dr. T Rajamannar Non Executive Director
View More

Sun Pharma Advanced Research Company FAQs

The Buying Price of Sun Pharma Advanced Research Company share is 124.06 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Sun Pharma Advanced Research Company stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Sun Pharma Advanced Research Company, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Sun Pharma Advanced Research Company shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Sun Pharma Advanced Research Company shares is -9.19. Useful to assess the stock's value relative to its book value.

To assess Sun Pharma Advanced Research Company’s valuation compare Sector P/E, P/B which are 21.12 & 2.65 with sector averages, along with growth rates and financial metrics.

The Market Cap of Sun Pharma Advanced Research Company is 4025.74 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Sun Pharma Advanced Research Company share price is 204.40 & 108.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Sun Pharma Advanced Research Company belongs to the Miscellaneous sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost